Agoracom Blog Home

Archive for the ‘CardioComm Solutions’ Category

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Putting Your Heartbeat Into The Cloud For Instant Diagnostics $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:40 PM on Friday, April 3rd, 2020

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

CardioComm Solutions Partners with CareOS to Bring Consumer ECG Monitoring into the Connected Home

  • Entered into a partnership agreement with CareOS SAS (France), a subsidiary of Baracoda Group, to provide consumer ECG monitoring technologies through the CareOS Poseidon smart mirror health and beauty hub
  • The partnership will see CardioComm’s FDA and Health Canada cleared GEMS™ ECG management software and Smart Monitoring ECG reading service integrated into the touch and gesture controlled smart mirror
  • GEMSTM software will be capable of recognizing ECG devices made by multiple device manufacturers which will permit CareOS customers more options in choosing a device of their preference.

Industry News

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

#Mhealth Project to Crowdsource Consumer Data for #Coronavirus Research – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:49 AM on Wednesday, April 1st, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

mHealth Project to Crowdsource Consumer Data for Coronavirus Research

  • UCSF researchers are deploying an mHealth app to gather information on daily health habits
  • They’re hoping to gain insight on how behaviors might affect the course of the virus or outcomes in those who are infected

By Eric Wicklund

March 31, 2020 – mHealth researchers are using smartphones to crowdsource Coronavirus research.

The University of California at San Francisco has launched COVID-19 Citizen Science (CCS), a project aimed at gathering insights from people around the world on the virus. Participants are being asked to download an mHealth app, complete a survey about their daily health habits, complete a weekly follow-up survey and pass it on to friends.

“We are asking each participant to share the link to recruit at least five others,” Gregory Marcus, MD, MAS, a professor at UCSF’s Department of Medicine and the project’s co-leader, said in a press release. “We want to demonstrate that the number of people signing up for this scientific study and contributing their data can increase exponentially, faster than the disease itself.”

Participants will also be able to provide continuous GPS data and information from mHealth wearables, such as Fitbit activity bands and smartwatches.

(For more coronavirus updates, visit our resource page, updated twice daily by Xtelligent Healthcare Media.)

The program is one of several aimed at using connected health platforms to study the pandemic. Just down the highway in San Diego, the Scripps Research Translational Institute has launched a project aimed at measuring the value of mHealth wearables in detecting emerging viral outbreaks.

Another project launched out of UCSF, meanwhile, is using mHealth wearables to monitor frontline care workers who’ve been exposed to the virus.

Marcos is no stranger to telehealth projects. In 2013 he helped to launch the Health eHeart Study, which used online and mHealth tools to collect and analyze heart health data. That, in turn, led to the launch of a study in 2018 that combined mHealth wearables with AI to determine whether a cardiac monitoring platform could help detect early signs of diabetes.

Marcos says CCS aims to identify behaviors, influences and factors that might affect the course of the virus and outcomes after infection, and he feels the study could be the largest-ever prospective epidemiological study of infectious diseases.

“Social distancing keeps many protected,” he said, “but joining together to contribute data will help us beat this thing.”

Source: https://mhealthintelligence.com/news/mhealth-project-to-crowdsource-consumer-data-for-coronavirus-research

‘Smart’ devices help reduce adverse outcomes of common heart condition #Mhealth – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 4:02 PM on Tuesday, March 31st, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

‘Smart’ devices help reduce adverse outcomes of common heart condition

  • mHealth devices, such as fitness trackers, smart watches and mobile phones, may enable earlier AF detection, and improved AF management through the use of photoplethysmography (PPG) technology
  • AF is the most common heart rhythm disturbance, affecting around one million people in the UK. People with AF are at increased risk of having a stroke and dying, as well as heart failure and dementia

by University of Liverpool

A new study, published in the Journal of the American College of Cardiology, highlights the feasible use of mobile health (mHealth) devices to help with the screening and detection of a common heart condition.

Atrial fibrillation (AF) is a heart rhythm condition that causes an irregular and sometimes, abnormally fast heart rate. In AF, the heart’s upper chambers (atria) contract randomly and sometimes so fast that the heart muscle cannot relax properly between contractions. This reduces the heart’s efficiency and performance—but also leads to a higher risk of blood clots.

AF is the most common heart rhythm disturbance, affecting around one million people in the UK. People with AF are at increased risk of having a stroke and dying, as well as heart failure and dementia. Currently, low detection due to lack of visible symptoms and non-adherence are major problems in current management approaches for patients with suspected AF.

Photoplethysmography technology

mHealth devices, such as fitness trackers, smart watches and mobile phones, may enable earlier AF detection, and improved AF management through the use of photoplethysmography (PPG) technology.

PPG is a simple and low-cost optical technique that can be used to detect blood volume changes in the microvascular bed of tissue. It is often used non-invasively to make measurements at the skin surface.

To help determine whether a mHealth technology-supported AF integrated management strategy would reduce AF-related adverse events, compared to usual care, an international team of researchers, led by Associate Professor Guo from Chinese PLA General Hospital in Beijing, and Professor Gregory Lip, Lead for the Liverpool Centre for Cardiovascular Science (LCCC)/Price-Evans Chair of Cardiovascular Medicine at University of Liverpool, conducted a randomised trial.

Central to the study was mobile health technologies developed by leading global technology companies, with a focus on using wearable smart devices such as those from Huawei, working in conjunction with a specially developed mobile app. These pieces of equipment and software can monitor a person’s vital signs with great detail and, most importantly for this study, 24 hours a day.

The specially designed mobile app not only charted the patient’s biometrics, it afforded clinicians the ability to offer integrated care throughout the duration of the trial. Doctors were able to periodically assess the patient’s updated statistics and contact them through the app to offer advice via the ABC care pathway. The ABC pathway, developed in part by the LCCS’ Professor Gregory Lip, is a set of guidance for patients and clinicians, which aims to promote a streamlined holistic approach to the management of AF, and ensure that the danger of complications is minimised.

The researchers enrolled a cluster of 3,324 AF patients aged over 18 years from 40 cities across China. The patients were randomized with 1678 receiving usual care and 1646 receiving integrated care based on a mobile AF Application (mAFA) incorporating the ABC Pathway: ‘A’ Avoid stroke; ‘B’ Better symptom management; ‘C’ Cardiovascular and other comorbidity risk reduction. All patients were followed up in outpatient clinics at 6 and 12 months.

Results

Upon completion of the study, the researchers were able to show that occurrences of stroke, systemic thromboembolism, death and rehospitalisation were significantly lower with those patients in the mHealth intervention group compared to those undergoing usual care (1.9% compared with 6%). Rehospitalisation rates were also notably reduced, with only 1.2% of patients in the intervention group needing to be readmitted to hospital, in comparison to 4.5% of patients in the control group.

In addition to these positive figures, subgroup analyses by gender, age, type of condition, risk score and comorbidities, demonstrated consistently lower risks for the composite outcome for patients receiving the mAFA intervention compared to usual care.

These results show an undeniable benefit for the adoption of an integrated approach to monitoring and treating cardiac conditions such as AF.

With smart technologies such as phones, watches and integrated smart home systems becoming increasingly accessible and affordable, the ability for clinicians and researchers to adopt this technology to passively and unobtrusively gather a seemingly unlimited amount of data and information on the global health population is offering boundless opportunity for assessing and treating all manner of diseases and conditions.

Integrated care approach

Associate Professor Guo, said: “Our study clearly highlights the need for an integrated care approach to holistic AF care, supported by mobile health technology, as it help to reduce the risks of rehospitalisation and clinical adverse events.”

Professor Lip, said: “Improved AF care requires early detection which enables the implementation of the priorities of AF management, which is as ‘easy as ABC’: Avoid stroke; Better symptom optimisation; Cardiovascular and risk factor management. Our clinical trial shows how the mAFA App and smart devices can improve detection of AF and the holistic management of AF patients, improving outcomes in this common heart rhythm disorder.”

Source: https://medicalxpress.com/news/2020-03-smart-devices-adverse-outcomes-common.html

The Tech That Could Be Our Best Hope for Fighting #COVID19 —and Future Outbreaks – SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 5:09 PM on Monday, March 30th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

The Tech That Could Be Our Best Hope for Fighting COVID-19—and Future Outbreaks

  • “The connectivity we have today gives us ammunition to fight this pandemic in ways we never previously thought possible,” says Alain Labrique, director of the Johns Hopkins University Global -mHealth Initiative.

By Alice Park

Battling a pandemic as serious as COVID-19 requires drastic responses, and political leaders and public-health officials have turned to some of the most radical strategies available. What began with a lockdown of one city in China quickly expanded to the quarantine of an entire province, and now entire countries including Italy. While social isolation and curfews are among the most effective ways to break the chain of viral transmission, some health experts say it’s possible these draconian measures didn’t have to become a global phenomenon. “If health officials could have taken action earlier and contained the outbreak in Wuhan, where the first cases were reported, the global clampdown could have been at a much more local level,” says Richard Kuhn, a virologist and professor of science at -Purdue University.

The key to early response lies in looking beyond centuries-old strategies and incorporating methods that are familiar to nearly every industry from banking to retail to manufacturing, but that are still slow to be adopted in public health. Smartphone apps, data analytics and artificial intelligence all make finding and treating people with an infectious disease far more efficient than ever before.

“The connectivity we have today gives us ammunition to fight this pandemic in ways we never previously thought possible,” says Alain Labrique, director of the Johns Hopkins University Global -mHealth Initiative. And yet, to date, the global public–health response to COVID-19 has only scratched the surface of what these new containment tools offer. Building on them will be critical for ensuring that the next outbreak never gets the chance to explode from epidemic to global pandemic.

Consider how doctors currently detect new cases of COVID-19. Many people who develop the hallmark symptoms of the -disease—fever, cough and shortness of breath—-physically visit a primary-care doctor, a health care provider at an urgent-care center or an emergency room. But that’s the last thing people potentially infected with a highly contagious disease should do. Instead, health officials are urging them to connect remotely via an app to a doctor who can triage their symptoms while they’re still at home.

“The reality is that clinical brick-and-mortar medicine is rife with the possibility of virus exposure,” says Dr. Jonathan Wiesen, founder and chief medical officer of MediOrbis, a telehealth company. “The system we have in place is one in which everyone who is at risk is potentially transmitting infection. That is petrifying.” Instead, people could call a telemedicine center and describe their symptoms to a doctor who can then determine whether they need COVID-19 -testing—without exposing anyone else.

Hundreds Flout Louisiana COVID-19 Gatherings Ban

In Singapore, more than a million people have used a popular telehealth app called -MaNaDr, founded by family physician Dr. Siaw Tung Yeng, for virtual visits; 20% of the physicians in the island country offer some level of service via the app. In an effort to control escalating cases of coronavirus there, people with symptoms are getting prescreened by physicians on MaNaDr and advised to stay home if they don’t need intensive care. Patients then check in with their telehealth doctor every evening and report if their fever persists, if they have shortness of breath or if they are feeling worse. If they are getting sicker, the doctor orders an ambulance to take those people to the hospital. Siaw says the virtual monitoring makes people more comfortable about staying at home, where many cases can be treated, instead of flooding hospitals and doctors’ offices, straining limited resources and potentially making others sick. “This allows us to care across distance, monitor patients across distance and assess their progression across distance,” says Siaw. “There is no better time for remote care monitoring of our patients than now.”

Other at-home devices and services currently being used in the U.S. allow patients to measure dozens of health metrics like temperature, blood pressure and blood sugar several times a day, and the results are automatically stored on the cloud, from which doctors get alerts if the readings are abnormal.

Telemedicine also serves as a powerful communication tool for keeping hundreds of thousands of people in a specific region up to date with the latest advice about the risk in their communities and how best to protect themselves. That can go a long way toward reassuring people and preventing panic and runs on health centers and hospitals.

Beyond individual-level care, the data gathered by telemedicine services can be mined to predict the broader ebb and flow of an epidemic’s trajectory in a population. In the U.S., Kaiser Permanente’s tele-medicine call centers are now also serving as a bellwether for an anticipated surge in demand for health services. Dr. Stephen Parodi, national infectious–disease leader at Kaiser Permanente, was inspired by a Google project from a few years ago in which the company created an algorithm of users’ flu–related search terms to determine where clusters of cases were mounting. Parodi started tracking coronavirus–related calls from the health system’s 4.5 -million members in Northern California in February. “We went from 200 calls a day to 3,500 calls a day about symptoms of COVID-19, which was an early indicator of community–based transmission,” he says. “Our call volume was telling us several weeks before the country would have all of its testing online that we have got to plan for a surge in cases.”

Source: https://time.com/5805622/coronavirus-pandemic-technology/

The #Tech That Could Be Our Best Hope for Fighting #COVID19 —and Future Outbreaks SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 2:45 PM on Thursday, March 19th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

The Tech That Could Be Our Best Hope for Fighting COVID-19—and Future Outbreaks

By Alice Park

  • Battling a pandemic as serious as COVID-19 requires drastic responses, and political leaders and public-health officials have turned to some of the most radical strategies available.
  • The key to early response lies in looking beyond centuries-old strategies and incorporating methods that are familiar to nearly every industry from banking to retail to manufacturing, but that are still slow to be adopted in public health
  • Smartphone apps, data analytics and artificial intelligence all make finding and treating people with an infectious disease far more efficient than ever before

What began with a lockdown of one city in China quickly expanded to the quarantine of an entire province, and now entire countries including Italy. While social isolation and curfews are among the most effective ways to break the chain of viral transmission, some health experts say it’s possible these draconian measures didn’t have to become a global phenomenon. “If health officials could have taken action earlier and contained the outbreak in Wuhan, where the first cases were reported, the global clampdown could have been at a much more local level,” says Richard Kuhn, a virologist and professor of science at -Purdue University.

The key to early response lies in looking beyond centuries-old strategies and incorporating methods that are familiar to nearly every industry from banking to retail to manufacturing, but that are still slow to be adopted in public health. Smartphone apps, data analytics and artificial intelligence all make finding and treating people with an infectious disease far more efficient than ever before.

“The connectivity we have today gives us ammunition to fight this pandemic in ways we never previously thought possible,” says Alain Labrique, director of the Johns Hopkins University Global -mHealth Initiative. And yet, to date, the global public–health response to COVID-19 has only scratched the surface of what these new containment tools offer. Building on them will be critical for ensuring that the next outbreak never gets the chance to explode from epidemic to global pandemic.

Consider how doctors currently detect new cases of COVID-19. Many people who develop the hallmark symptoms of the -disease—fever, cough and shortness of breath—-physically visit a primary-care doctor, a health care provider at an urgent-care center or an emergency room. But that’s the last thing people potentially infected with a highly contagious disease should do. Instead, health officials are urging them to connect remotely via an app to a doctor who can triage their symptoms while they’re still at home.

“The reality is that clinical brick-and-mortar medicine is rife with the possibility of virus exposure,” says Dr. Jonathan Wiesen, founder and chief medical officer of MediOrbis, a telehealth company. “The system we have in place is one in which everyone who is at risk is potentially transmitting infection. That is petrifying.” Instead, people could call a telemedicine center and describe their symptoms to a doctor who can then determine whether they need COVID-19 -testing—without exposing anyone else.

In Singapore, more than a million people have used a popular telehealth app called -MaNaDr, founded by family physician Dr. Siaw Tung Yeng, for virtual visits; 20% of the physicians in the island country offer some level of service via the app. In an effort to control escalating cases of coronavirus there, people with symptoms are getting prescreened by physicians on MaNaDr and advised to stay home if they don’t need intensive care. Patients then check in with their telehealth doctor every evening and report if their fever persists, if they have shortness of breath or if they are feeling worse. If they are getting sicker, the doctor orders an ambulance to take those people to the hospital. Siaw says the virtual monitoring makes people more comfortable about staying at home, where many cases can be treated, instead of flooding hospitals and doctors’ offices, straining limited resources and potentially making others sick. “This allows us to care across distance, monitor patients across distance and assess their progression across distance,” says Siaw. “There is no better time for remote care monitoring of our patients than now.”

Other at-home devices and services currently being used in the U.S. allow patients to measure dozens of health metrics like temperature, blood pressure and blood sugar several times a day, and the results are automatically stored on the cloud, from which doctors get alerts if the readings are abnormal.

Telemedicine also serves as a powerful communication tool for keeping hundreds of thousands of people in a specific region up to date with the latest advice about the risk in their communities and how best to protect themselves. That can go a long way toward reassuring people and preventing panic and runs on health centers and hospitals.

Beyond individual-level care, the data gathered by telemedicine services can be mined to predict the broader ebb and flow of an epidemic’s trajectory in a population. In the U.S., Kaiser Permanente’s tele-medicine call centers are now also serving as a bellwether for an anticipated surge in demand for health services. Dr. Stephen Parodi, national infectious–disease leader at Kaiser Permanente, was inspired by a Google project from a few years ago in which the company created an algorithm of users’ flu–related search terms to determine where clusters of cases were mounting. Parodi started tracking coronavirus–related calls from the health system’s 4.5 -million members in Northern California in February. “We went from 200 calls a day to 3,500 calls a day about symptoms of COVID-19, which was an early indicator of community–based transmission,” he says. “Our call volume was telling us several weeks before the country would have all of its testing online that we have got to plan for a surge in cases.”

On the basis of the swell in calls nationwide, the hospital system is considering suspending elective surgeries based on local circumstances, in part to ensure that ventilators and other critical equipment would be available for an anticipated influx of COVID-19 patients with severe symptoms. Kaiser doctors also postponed appointments for routine mammograms and other cancer–screening tests and cut back on in-person appointments by turning most noncritical visits into virtual visits.

The COVID-19 pandemic may be the trial by fire that telemedicine finally needs to prove its worth, especially in the U.S. Despite the fact that apps and technology for virtual health visits have existed for several decades, uptake in the country has been slow. Medicare only recently began reimbursing for telemedicine visits at rates comparable to in-person visits, and states have just begun to relax licensing regulations that prevent doctors in one state from -remotely treating patients in another state. “This -pandemic is almost like us crossing the Rubicon,” says Wiesen of MediOrbis. “It’s a clarion call for America and for the world on how important telemedicine is.” Parodi agrees. “I think this pandemic will bring in a fundamental change in the way we practice medicine and in the way the health care system functions in the U.S.,” he says. “We’re going to come out of this and -realize a lot of health care visits don’t have to be in person.”

Other tech innovations that haven’t fully made their way to the public-health sector could also play a critical role in controlling this -pandemic—and future outbreaks. Taking a closer look at health-related data, such as electronic health records or sales of over-the-counter medications, can provide valuable clues about how an infectious disease like COVID-19 is moving through a population. Retail drugstores track inventory and sales of nonprescription fever reducers, for example, and any trends in those data might serve as an early, albeit crude, harbinger of growing spread of disease in a community. And given the proliferation of health–tracking apps on smartphones, analyzing data trends like a rise in average body temperature in a given geographical area could provide clues to emerging clusters of cases.

Geotracking on phones, while controversial because of privacy issues, can also streamline the tedious task of contact tracing, in which scientists try to manually trace infected patients’ whereabouts to find as many people with whom they had direct contact and who could have been infected. In South Korea, this strategy helped identify many of the contacts of members of a Seoul church that formed the first major cluster of infections in the country. In countries with a less robust health care infrastructure, smartphones can be critical for gathering information about emerging infections on the ground. In Bangladesh, says Labrique, programs created to canvass for noncommunicable diseases like hyper-tension and diabetes are now being modified to include questions about COVID-19 symptoms. These types of real-time data can rapidly provide a snapshot of where and how fast the disease might be spreading, to distribute health care workers and -equipment where they’re needed most.

It’s all about catching these cases as early as possible, to minimize the peak of a pandemic so the health system doesn’t get overwhelmed. But it’s not just about seeing the trends. Flattening the surge of an infectious disease also requires action, and that’s where the advice gets -muddier—but also where Big Data and artificial intelligence (AI) can provide clarity.

By deeply analyzing the care that every COVID-19 patient receives, for example, AI can tease out the best treatment strategies. Jvion, a health care analytics company, is using AI to study 30 million patients in its data universe to identify people and communities at highest risk of COVID-19 on the basis of more than 5,000 variables that include not just medical history but also lifestyle and socioeconomic factors such as access to stable housing and transportation. Working with clients that include large hospital systems as well as small remote health centers, Jvion’s platform creates lists of people who should be contacted pro-actively to warn them about their vulnerability so health providers can create a care plan for them.

In the case of COVID-19, that might include social distancing and avoiding large public gatherings. To help public-health departments better prepare communities for this and future outbreaks, the company has communicated with the U.S. Centers for Disease Control and Prevention to share what it has learned.

Privacy issues, however, nest in every single byte of data about a person’s health. So the power of AI methods in controlling outbreaks depends on how effectively data can be anonymized. Only when people are assured of privacy can algorithms help to navigate the next big hurdle: predicting surges in cases that strain health care personnel and availability of supplies like ventilators, masks and gowns.

If COVID-19 teaches public-health officials one thing, it’s that there are now tools available to help contain an infectious disease before radical measures like quarantines and curfews are needed. “What we were doing 10 years ago and what we are doing now is vastly different,” says Wiesen. “There is a tremendous opportunity here, and hopefully by [the next pandemic], the use of technology and data analytics is going to be light-years ahead of where it is today.”

Source: https://time.com/5805622/coronavirus-pandemic-technology/

Why #5G enabled healthcare #Mhealth is important for patients and spatial computing SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 1:03 PM on Wednesday, March 18th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Why 5G enabled healthcare is important for patients and spatial computing

By Health Europa

By empowering new tools, 5G enabled healthcare may help aid in caring for patients and preparing for complex medical procedures.

  • While augmented reality (AR), virtual reality (VR) and spatial computing are already being used in healthcare on a limited basis, 5G enabled healthcare may eventually further enhance a doctor’s ability to deliver innovative, less invasive treatments.
  • Among 5G’s many ultimate potential applications, some of the most exciting involve its role in simulating complex medical scenarios and enabling alternative treatments for the critically ill.

5G enabled healthcare

5G is the fifth generation of cellular wireless technology, which can offer massive connection power and fast internet speed for data transfer. Implementation of 5G technology accelerated the demand for various healthcare technologies such as the Internet of Medical Things, AR/VR, artificial intelligence (AI), remote medical learning, and remote patient monitoring to name a few.

Patient real time information is important data for doctors to take decisions in a critical situation. This has accelerated the demand for advanced technologies in the healthcare sector. For instance, telemedicine requires an advanced network that offers support in real time, providing high-quality video communication without slowing down the facility’s network. Integration of 5G network in existing infrastructure provides real time data transfer of images, documents, and real time videos for video-based medical consultations, to improve the quality of care.

North America held a dominant share of the global 5G enabled healthcare services market in 2019. It is expected to continue its dominance throughout the forecast period. The US and Canada are the major countries that drive the 5G enabled healthcare services market in the region.

Demand for 5G

The aging population is expected to increase the demand for advanced solutions such as mHealth solutions, and home healthcare, which require high-speed internet. According to the Population Reference Bureau, in 2018, 15% of the total North American population was above the age of 65 and is expected to reach 23% by 2050. Hence, the increasing aging population is accelerating the demand for 5G enabled healthcare services.

The 5G enabled healthcare services market in Asia Pacific is expected to expand at a fast-paced CAGR during the forecast period. India, China, Japan, and Australia are major countries of the 5G enabled healthcare services market in the region.

Increasing adoption of advanced communication solutions in the healthcare industry, majorly in developing countries where health care systems are often unprepared to tackle the challenges of a growing elderly population, has raised the need for high-speed internet services in the healthcare sector. Hence, this augments the adoption rate of 5G services in the healthcare industry.

Source: https://www.healtheuropa.eu/why-5g-enabled-healthcare-is-important-for-patients-and-spatial-computing/98656/

#Coronavirus Scare Gives #Telehealth an Opening to Redefine Healthcare #Mhealth SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 6:12 PM on Thursday, March 12th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Coronavirus Scare Gives Telehealth an Opening to Redefine Healthcare

With the coronavirus threatening to become a pandemic, health systems and telehealth vendors see this as an opportunity to bring connected health to the forefront – and reshape the future of healthcare.

By Eric Wicklund

March 05, 2020 – As Congress votes on a funding package that includes Medicare waivers for some telehealth services and the Health Information and Management Systems Society (HIMSS) cancels its conference in Florida, healthcare providers across the country are looking at how connected care programs can be used to handle the coronavirus – also called COVID-19 – threat.

Most see the exercise as an extension of their preparations for flu season. Some see this as an opportunity to lobby for telehealth adoption across the board, saying a possible epidemic offers ample evidence of the value of telehealth and mHealth.

Defining Telehealth’s Value in a Changing Landscape

“COVID-19 is different because we do not know all the factors surrounding transmission and its effects on patients,” Jason Hallock, Chief Medical Officer for SOC Telemed, points out. â€œBecause coronavirus is new and there have been a significant number of deaths, the uncertainty surrounding that is scaring both patients and the general public. Our healthcare workers do not have all the answers yet. Telehealth providers are challenged to make recommendations when there are still many unknowns. Telemedicine can be useful to evaluate and reassure patients in alternative settings, and also can be used to help patients decide who needs to be seen in the hospital or an alternative setting like an urgent care.”

Hallock says telehealth can help by enabling healthcare providers to treat isolated patients, thus preventing the spread of what has so far been an extremely contagious virus.

In a Q&A with mHealthIntelligence, Peter Antall, MD, President and Chief Medical Officer for American Well, offered an in-depth take on how telehealth might be used.

READ MORE: Scripps Researchers Use mHealth Wearables to Track Flu Outbreaks

Q. Telehealth has long been seen as an ideal means of expediting care during flu outbreaks. How is the coronavirus scare different? Does this pose any unique challenges that telehealth can address?

A. The novel coronavirus, or COVID-19, is similar to influenza in how it is transmitted (airborne), how symptoms manifest themselves, and the fear it stirs among those individuals at risk. When evaluating patients through telehealth, we use similar methodology as that used for influenza, except that the current Centers for Disease Control and Prevention (CDC) recommendations call for risk stratification based on known exposure or travel to endemic areas and referral for testing for those at high risk or those who are sick enough to need hospital care. Also, unlike with influenza, there are no current specific treatments, like antivirals, for the coronavirus at this time. 

If local person-to-person spread expands to wide community spread, we expect care will need to evolve to a method that is quite similar to how we treat influenza today. Under those circumstances, we will likely begin diagnosing coronavirus-like illness (CLI) on a clinical basis, without testing. We would likely then only be expected to refer inpatients with CLI who need hospital care clinically, while those with milder symptoms will likely be treated and monitored at home so as to limit the spread of this disease and not overwhelm our healthcare facilities.

In this way, telehealth is an ideal venue for an outbreak like this. We can increase access to care. We can offer care that is commensurate with the acuity and nature of the symptoms and make referrals as needed. This helps with infection prevention and control and also allows patients to receive their care in the home without exposing themselves to further illness.

One other notable point is the potential for telehealth to help in providing routine care for other conditions and offset coronavirus fears in the . Patients have other healthcare needs unrelated to coronavirus, but many are afraid to go to healthcare settings for fear of catching disease. This has begun to result in a migration of patients to telehealth. For example, on February 25, we saw telehealth urgent care patient volume that was 11 percent higher than expected. Many patients are now sharing anecdotes indicating they were afraid to sit in a waiting room, so they used telehealth instead.

READ MORE: Using Telehealth Technology for Care Coordination During a Disaster

Q. Are there new tools or technologies available that can be useful in dealing with the coronavirus?

A. Telehealth itself is a tool in this fight. Keep in mind that there are many varieties of telehealth. It can be used to connect a doctor or other provider with a patient in the home via smartphones or tablets. It can also be used for provider (specialist)-to-provider consultations in remote areas, for example. Telehealth carts also exist in healthcare settings and can be used not only to import care, but also to limit healthcare workers’ exposure to the virus by using a cart in the isolation room.  We see patients primarily through live video interactions, but we also can fall back to informed telephone calls, synchronous chatting for therapy and asynchronous secure messaging for ongoing communications.

The use of symptom trackers and chatbots is another promising area for coronavirus response. These technologies allow algorithms to be created and adjusted as more is learned about the coronavirus. These bots interact with patients and can perform assessments, triage and ongoing support. The bots can even escalate an interaction to a telehealth encounter or refer the patient for in-person care.

Finally, home monitoring and medical tricorders are another promising approach to care. Traditional remote patient monitoring has established value for managing certain chronic conditions, but the next wave of home monitoring includes consumer devices like smartwatches (like the Apple Heart Study), home TVs, and home medical tricorders like Tytocare that can perform a remote examination. These tools aid clinicians and patients and provide more robust health data conveniently from the home setting. Providers can also use the data generated to better care for the patient or regularly monitor certain conditions.

Q. What must care providers know about telehealth before using it to deal with the coronavirus?

READ MORE: HHS Is Looking For mHealth Devices That Can Diagnose Influenza

A. Providers must know and understand their role in this or any other healthcare crisis. They should be well informed and trained to follow current CDC or World Health Organization guidelines. They should also understand that telehealth is a powerful tool for helping fight this outbreak. And they should know that telehealth is a safe way to treat and/or triage these patients. Whether the provider is a primary telehealth provider or is not using telehealth today, there is a real opportunity to participate and play a role in the response. 

Providers who have a brick-and-mortar practice should be encouraged to use telehealth as a triage tool. Providers also need to understand that during this time, patients with other non-respiratory conditions also need care. These patients should be afforded a safe way to access care without risk of infection. Telehealth is also a tool to aid in this process, as some patients are fearful of going to healthcare facilities right now. The office-based provider can likewise process other patients by practicing this way.

Q. What are the barriers or challenges associated with using telehealth to deal with the coronavirus scare?

A. Telehealth visits are typically sufficient to complete a robust initial assessment. This allow the provider to assign a risk category, make other diagnoses, or deem the patient as “worried well.” Some patients may require additional care, as most telehealth in the home lacks certain medical peripherals that might be needed. Other reasons for referral would include a high-risk patient who needs to be tested or a patient who requires escalation of care due to the severity of their illness. Telehealth visits are generally sufficient for screening patients, assigning a risk category, answering questions and recommending the next steps a patient should take.

The barriers to telehealth—such as instances when the patient and provider do not yet have a relationship—are easily overcome providers receive similar training around the use of telehealth and as longitudinal patient records become more available to guide care. Occasionally the lack of medical peripherals or the inability to touch the patient during an exam is a barrier, as some patients need hands on care (e.g., IV, procedures). We have policies that mitigate these problems in most cases. However, on occasion, a telehealth patient must be referred for in-person evaluation.

Q. Is there anything that the CDC or any other government agency can do to support telehealth adoption to deal with the coronavirus? 

A. It is useful for the CDC (and the WHO) to highlight the important role of telehealth in this outbreak because it certifies our role within the broader medical community and raises awareness about this tool.

It would be helpful if the CDC were to make specific recommendations to telehealth providers that relate to telehealth evaluation of the coronavirus and associated referrals, coding and monitoring. It would also be helpful if the CDC were to play a role in advocacy efforts focused on government reimbursement, particularly in this emergency situation. Efforts to increase consumer awareness about telehealth as a safe option for care also could prove essential. When this outbreak settles down, we would encourage the CDC and HHS to collaborate around coronavirus standards of care and preparedness so that patients can expect telehealth providers to be ideally prepared and well-coordinated for the next outbreak and so that we can offer high-quality care in this manner to all Americans.

We also believe that our public health system would benefit greatly from owning its own telehealth network infrastructure. This would allow the CDC to better scale up, solve for geography and improve surveillance. It would even allow its public health workers to use technology to monitor patients under quarantine in the home, saving themselves travel and limiting healthcare workers’ exposure.

Q.  What more can be done with telehealth in the future to plan for these types of outbreaks, or to perhaps address them before they become serious?

A. Much needs to be done throughout our country to better prepare. We need permanent leaders placed at the U.S. Department of Health and Human Services, the National Institutes for Health, the US Department of Homeland Security and other key areas, and we need to reinstate a pandemic-preparedness role at the National Security Council. We need to fund international efforts to improve screening and research for emerging diseases, and we need surveillance programs and good international coordination. We need to fund (not decrease funding) for our frontline groups, like the CDC, HHS and local public health services. These are our fighters, and we need them ready and funded properly as an outbreak like this is a national security issue. We need stockpiles of materials. Finally, we should be partnering with the pharmaceutical industry on affordable medications and vaccine research.

Our national telehealth operation today acts like an emergency alert system. We see cases or potential cases before they are reported. At American Well, our influenza activity indicator map is more accurate and more timely than that of the CDC. We already play a meaningful role in many disease states, including outbreaks. There are still many adoption and awareness challenges that exist when it comes to telehealth. Hopefully this unfortunate event will help consumers, providers and others start to more clearly see how they can and should use telehealth for future healthcare needs.

Another barrier that we continue to work on is that of reimbursement. Telehealth is a cost-effective way of receiving care, but it is still not always a covered benefit by insurance. Most commercial plans are reimbursing and there is increasing adoption in Medicare Advantage and Medicaid managed care. But there are still gaps, including a big gap in fee-for-service coverage for Medicare coverage in the home. Efforts at reform are underway (see the CONNECT Act), but more work needs to be done so that all Americans can take advantage of this amazing service.

Additionally, with coordination being so important during outbreaks like this, the simple step of integrating telehealth with other health information systems, such as EHRs or clinical-decision support, can make care more seamless and foster better care coordination. This would speed up access to critical care. Case in point: Consider a scenario where a patient consults with a physician over a telehealth network and displays symptoms of COVID-19 while presenting one or more correlating risk factors. The physician could easily document the experience, dispatch an alert to a local ED, and ensure precautions are taken by medical staff to usher this patient into a contained room or unit to begin testing and treatment. We’re working to ensure this type of communication is happening at all levels, but there’s still much room for improvement on this front. 

Health System Execs Respond to the Threat

In an op-ed prepared for the Alliance for Connected Care, Todd J. Vento, MD, MPH, Intermountain Healthcare’s Medical Director of Infectious Diseases Telehealth Service; Ethan Booker, MD, Medical Director of MedStar’s Telehealth Innovation Center; and Lawrence “Rusty” Hofmann, MD, Stanford Health’s Medical Director of Digital Health, made their pitch for telehealth:

“Telehealth, which has proven to be a very useful tool in addressing patient needs during flu season, will improve our collective ability to address COVID-19 if it hits on a larger scale. Telehealth offers several advantages over in-person care in the event of a pandemic.

One key advantage of telehealth is speed,” the three wrote. “Patients can access clinicians 24/7 without an appointment or physical trip to the doctor. Using telehealth, our providers in the Stanford Primary Care team, MedStar Health and Intermountain Healthcare have been actively evaluating and treating patients with influenza.  Current providers at Stanford Health estimate that almost 50% of patients are getting oseltamivir (Tamiflu).  Because there is no current, specific medication for Coronavirus, we must be able to advise patients of reasonable self-directed treatment and surveillance to keep them home. 

Keeping patients at home is a significant advantage of telehealth. In-home video visits limit community exposure by allowing patients to avoid contact with other patients in waiting rooms and direct contact with providers during the exam.  Our health systems have providers who are equipped to work from their own homes, significantly increasing the safety of providers and bolstering the workforce to respond to crisis.  Workforce readiness in a crisis that may include such dramatic measures as school and day care closures is a significant concern for health systems which may be strained to respond.  Health systems are also using telehealth to continue surveillance of patients already identified as at risk while keeping them at home.

Next, telehealth ensures that treatment in brick-and-mortar settings is reserved for high-need patients.  Moreover, with patients being seen in their own homes, providers and health systems will be able to triage and screen exponentially more patients with telehealth vs. an in-person visit.

Finally, telehealth allows patients who do not have access to infectious diseases (ID) specialists to access this specialized care from the small number of experts across the country. When Intermountain first offered ID telehealth consultation to rural systems throughout the west, one provider fielded 1,000 consultation requests in the first fifteen months. To date, the service has provided telehealth care to over 4,700 patients, 50 percent of whom are over 65 years old.

Each of these advantages illustrate how telehealth can thwart the spread of COVID-19 and stop it from overwhelming our already stretched medical system.”

The three health executive also urged lawmakers to take action to reduce barriers to telehealth that have kept adoption low:

“Congress must act to ensure that seniors – a particularly vulnerable population generally and for this virus in particular – are able to receive necessary triage and care through telehealth. 

Today, there are restrictions in Medicare that prevent providers outside of very rural areas from being paid for care provided through telehealth. As a result, many providers do not offer telehealth services to seniors. The lack of reimbursement creates a perverse incentive of encouraging patients to come for in-person care, which will only overwhelm our health system as well as augment the virus’s spread.

Congress must give the Secretary of Health and Human Services the ability to waive these restrictions in times of public health emergencies. As part of the bipartisan, bicameral CONNECT for Health Act, telehealth champions in Congress foresaw this need and drafted a provision that would give the Secretary the ability to waive telehealth restrictions just as he/she would waive Conditions of Participation, Stark Laws licensure, or other requirements when public health emergencies are declared.”

Source: https://mhealthintelligence.com/news/coronavirus-scare-gives-telehealth-an-opening-to-redefine-healthcare

Healthcare IT #Mhealth Market Worth $511.06 Billion by 2027 SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 1:15 PM on Monday, March 9th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Healthcare IT Market Worth $511.06 Billion by 2027

  • Healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

London, March 06, 2020 – According to a new market research report “Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare)- Global Forecast to 2027”, published by Meticulous Research®, the healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

Health Information Technology (Healthcare IT) is a broad term that defines the technology and infrastructure utilized to record, analyze, and share patient health data in healthcare organizations. The aim of Healthcare IT solutions is to offer better care for patients and help accomplish health equity. It also endorses recording of patient data to improve healthcare delivery and allow for analysis of information for both healthcare practitioners and ministry of health/government agencies.

With increasing pressure to curtail healthcare cost and improve healthcare quality, investments in healthcare IT are gaining traction and are largely driven by the need for savings, economies of scale, and improving cash flow. According to a survey performed by Octopus group, more than 100 global institutional investors have planned to increase their investment in healthcare infrastructure, including health IT, by $200 billion over the next five years. By adopting various healthcare IT solutions such as EHR, PACS, and CPOE among others, healthcare organizations have reduced the operational cost and improved savings along with better patient care. For instance, with increasing adoption of Cerner Dynamic Documentation platform, Northern Light Health (U.S.) saved an estimated $1.3 million annually, by increasing provider efficiency, improving satisfaction with their electronic health record, and streamlining the discharge process. Similarly, by adopting Cerner ITWorks, University of Missouri Health Care (U.S.) reduced the organization’s IV obsolescence rate by more than 43% over three months. In addition, the university also adopted Cerner’s revenue cycle management solutions in 2018.

The healthcare IT solutions market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2027 – by product, component, delivery mode, end-user, and geography. The study also evaluates industry competitors and analyzes their market share at the global and regional level.

Based on product type, the healthcare providers solutions segment accounted for the largest share of the healthcare IT market and is slated to grow faster during the forecast period. The large share of this segment is primarily attributed to the factors such as growing focus on patient safety & care, increasing demand for integrated healthcare solutions, rising investments in development of healthcare infrastructure in emerging countries, increasing number of government initiatives & regulatory mandates on implementing eHealth solutions, increasing demand for quality healthcare, and rising awareness about electronic health records (EHRs). In addition, growing geriatric population & related ailments and patient workload on healthcare systems across the globe are also driving adoption of digitization solutions among healthcare providers.

Based on component type, the services segment held the largest share of the overall healthcare IT market. The largest share of this segment is mainly attributed to the increasing need to reduce healthcare costs, shift towards cloud-based services, rising adoption of digital solutions across healthcare organizations, and growing need to reduce administrative overheads of the healthcare industry.

Based on delivery mode, the overall healthcare IT market is segmented into web/cloud based and on-premises. Web & cloud-based solutions accounted for the largest share of the overall healthcare IT solutions market owing to its benefits such as on lower upfront cost, on-demand self-serving deployment model, excessive storage flexibility, and greater security.

Based on the end user, healthcare providers held the largest share of the overall healthcare IT market and is projected to grow at a fastest CAGR during the forecast period. The largest share of this segment is mainly attributed to rising patient volume, growing awareness about electronic health records (EHRs), growing healthcare spending by the countries across globe, and increasing adoption of healthcare IT solutions by healthcare providers.

The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past 4 years (2016–2019). The healthcare IT solutions market has witnessed number of new product launches, agreements, partnerships & collaborations, expansions, and acquisitions in the recent years. For instance, in October 2019, Cerner collaborated with ResMed (U.S.) to help providers make more informed treatment decisions, control costs, and deliver seamless care across health systems. Similarly, in July 2019, McKesson opened its new distribution center in Puyallup, Washington, U.S. to serve hospitals, health systems, community pharmacies, and national retail pharmacies across the state of Washington.

The key players operating in the global healthcare IT market are McKesson Corporation (U.S.), Optum Health (U.S.), International Business Machine Corporation (IBM) (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth, Inc. (U.S.), Epic Systems Corporation (U.S.), Dell Technologies Inc. (U.S.), GE Healthcare (U.S.), Cerner Corporation (U.S.), Oracle Corporation (U.S.), Cognizant Technology Solutions Corporation (U.S.), Nuance Communications, Inc. (U.S.), eClinicalWorks (U.S.) NextGen Healthcare, Inc. (U.S.), Computer Programs and Systems, Inc. (CPSI) (U.S.), Conifer Health Solutions, LLC. (U.S.), 3M Company (U.S.), Koninklijke Philips N.V. (The Netherlands), and Infor, Inc. (U.S.) among others.

Source: https://www.globenewswire.com/news-release/2020/03/06/1996384/0/en/Healthcare-IT-Market-Worth-511-06-Billion-by-2027-Exclusive-Report-by-Meticulous-Research.html

DEA Proposes New #Mhealth Rule for Substance Abuse Treatment SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:14 PM on Thursday, March 5th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

DEA Proposes New Mhealth Rule for Substance Abuse Treatment

A proposed rule change would allow providers to use mHealth tools more freely in substance abuse treatment programs, but it isn’t the rule that telehealth advocates have been anticipating.

By Eric Wicklund

March 04, 2020 – Federal officials have proposed easing restrictions on the use of mHealth in substance abuse programs – but the changes aren’t what everyone has been expecting.

Under a notice of proposed rulemaking published last month in the Federal Register, the US Drug Enforcement Agency would allow registered narcotic treatment programs (NTPs) using “mobile components” to consider those connected health elements as a coincident activity.

“The NTP registrants that operate or wish to operate mobile components (in the state that the registrant is registered in) to dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment would not be required to obtain a separate registration for a mobile component,” a summary of the rule states.

“This proposed rule would waive the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed for those NTPs with mobile components that fully comply with the requirements of the proposed rule, once finalized,” the summary continues. “These revisions to the regulations are intended to make maintenance or detoxification treatments more widely available, while ensuring that safeguards are in place to reduce the likelihood of diversion.”

The notice is different from what telehealth and mHealth providers have been waiting for: a rule that would ease federal restrictions on the prescription of scheduled drugs via telemedicine, and one that federal officials had been expected to unveil. It even prompted Virginia Sen. Mark Warner to issue a press release congratulating the DEA on making that move.

“The opioid and addiction epidemic has had a devastating impact on communities in Virginia and across the country,” Warner, who had sent a letter to the DEA in January, said in a press release that has since been deleted. “We need to use every tool at our disposal to ensure that individuals struggling with addiction can access the treatment they need, and telehealth is an important part of that. I am pleased the DEA has finally issued proposed rulemaking that will improve telehealth access for these patients and I hope they will work quickly to finalize this rulemaking once stakeholders have had an opportunity to weigh in.”

With the Special Registration for Telemedicine Act of 2018, which was part of the SUPPORT for Patients and Communities Act signed into law by President Donald Trump in late 2018, the DEA had until October 24, 2019 to set the ground rules for providers with a special registration to prescribe controlled substances.

That deadline passed without action. In November, the Justice Department announced plans to issue a proposed rule to create that registration process. But nothing has happened since then, and the DEA and other federal agencies have refused to give any updates.

Last month’s ruling leaves healthcare providers looking for more leeway in treating substance abuse issues both pleased and disappointed. It’s a step in the right direction for programs using digital health tools, but not the leap forward that so many have been anticipating.

Source: https://mhealthintelligence.com/news/dea-proposes-new-mhealth-rule-for-substance-abuse-treatment

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Putting Your Heartbeat Into The Cloud For Instant Diagnostics $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 6:03 PM on Monday, March 2nd, 2020

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

Physician Groups Order The Heartcheck(TM) Cardibeat For In-Home Arrhythmia And Atrial Fibrillation Monitoring

  • Confirms market traction with orders being placed by physician groups for the newly launched HeartCheck™ CardiBeat Handheld ECG monitor and GEMS™ Mobile Smartphone app for prescribed in-home arrhythmia monitoring.
  • Partners in Advanced Cardiac Evaluation, the largest arrhythmia practice in Ontario (Canada) placed a first order of the HeartCheck™ CardiBeat Handheld ECG monitors and is recommending its patients to use the devices for one year of in-home, self-monitoring with an emphasis on detecting a recurrence of Atrial Fibrillation following cardiac ablation treatment for AF.

Industry News

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.